TRUEtrack and TRUEbalance Blood Glucose Monitoring System 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Nipro Diagnostics 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2013-10-31
  • 사례 출판 날짜
    2013-10-31
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: nipro diagnostics truetrack and truebalance blood glucose monitoring system the medicines and healthcare products regulatory agency (mhra), united kingdom has posted a field safety notice concerning two models of blood glucose monitoring systems: i) truetrack (private label: wellion smart system, stada gluco check); & ii) truebalance (private label: wellion smart system 2), manufactured by nipro diagnostics. during a specific reconfiguration process in the company’s establishment in florida, usa where unused blood glucose meters in their original packaging are returned from customers and reconfigured with the appropriate unit of measure for a different geographic market to which they will be shipped, the unit of measure was set incorrectly on a small subset of reconfigured truebalance and truetrack meters. as the result of a process error in the reconfiguration process, certain meters may display: mmol/l as the unit of measure instead of mg/dl; or mg/dl as the unit of measure instead of mmol/l. for meters with incorrect mmol/l unit: in the event the user is unable to identify that the meter is displaying an incorrect unit of measure (mmol/l), the user may interpret the reading as abnormally low, depending on the user’s actual blood glucose value. based on this sequence of events, the user will not over medicate but may unknowingly remain in a hyperglycemic state. for meters with incorrect mg/dl unit: in the event the user is unable to identify that the meter is displaying an incorrect unit of measure (mg/dl), the user may interpret the reading as higher or much higher than expected, depending on the user’s actual blood glucose value. based on this sequence of events, the insulin user may over medicate and unknowingly remain in a hypoglycemic state or possibly over medicate, which may result in death or irreversible harm. there are no reports of adverse events or injury to date. users are advised to contact their supplier to see if their products are affected and the necessary actions for returning the devices if affected. according to the manufacturer, the affected products were not distributed in hong kong. for details, please visit the following mhra website: http://www.Mhra.Gov.Uk/safetyinformation/safetywarningsalertsandrecalls/fieldsafetynotices/con326483 posted on 31 october 2013.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: Nipro Diagnostics TRUEtrack and TRUEbalance Blood Glucose Monitoring System
  • Manufacturer

Manufacturer